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Abstract
Background: The high incidence of renal insufficiency in patients with Peripheral Arterial Disease raises the
concern for nephrogenic systemic fibrosis (NSF) with respect to contrast enhanced MRA. The risk of NSF is
eliminated with non-contrast enhanced magnetic resonance angiography. The purpose of the current study is to
compare image quality and diagnostic performance of non-contrast enhanced Quiescent Interval Single Shot (QISS)
magnetic resonance angiography at 3 T versus CT angiography for evaluation of lower extremity Peripheral Arterial
Disease (PAD).
Methods: 32 consecutive patients (23 male, 9 female, age range 40–81 years, average age 61.97 years) with
clinically suspected lower extremity PAD underwent QISS MRA and CTA. 19 of 32 patients underwent Digital
Subtraction Angiography (DSA). Image quality of MRA was compared with CTA by two radiologists with 10 and
8 years’ experience according to a 4-point scale. The Kappa test was used to determine the intermodality
agreement between MRA and CTA in stenosis assessment, and interobserver agreement with each method.
Sensitivity and specificity of CTA and MRA in detecting hemodynamically significant stenosis (≥50 %) were
compared, with DSA serving as reference standard when available.
Results: Image quality of QISS MRA was rated 3.70 ± 0.49 by reader 1, and 3.72 ± 0.47 by reader 2, significantly
lower than that of CTA (3.80 ± 0.44 and 3.82 ± 0.42, P < 0.001 for both readers). Intermodality agreement between
MRA and CTA was excellent for assessment of stenosis (Kappa = 0.923 ± 0.013 for reader 1, 0.930 ± 0.012 for reader
2). Interobserver agreement was 0.936 ± 0.012 for CTA and 0.935 ± 0.011 for MRA. For readers 1 and 2 respectively,
the sensitivity of QISS was 94.25 and 93.26 % (versus 90.11 and 89.13 % for CTA, P > 0.05), and specificity of QISS
was 96.70 and 97.75 % (versus 96.55 and 96.51 % for CTA, P > 0.05). For heavily calcified segments, sensitivity of
QISS (95.83 and 95.83 %) was significantly higher than that of CTA (74.19 and 76.67 %, P < 0.05).
Conclusion: QISS is a reliable alternative to CTA for evaluation of lower extremity PAD, and may be suitable as a
first-line screening examination in patients with contraindications to intravenous contrast administration.
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Background
Peripheral arterial disease (PAD) affects more than 5 mil-
lion adults in the United States [1], and the morbidity as-
sociated with PAD is increasing duo to the aging
population. Accurate diagnosis of PAD is essential for
treatment and management [2]. Ankle brachial index
(ABI) measurement is a sensitive test and is often the first
line test performed to evaluated PAD [3]. Color Doppler
ultrasonography (CDU) is widely utilized in patients with
chronic symptomatic limb ischemia, as it is a safe, nonin-
vasive, and inexpensive examination [4]. However, CDU
does not fully depict the entirety of the lower extremity
vasculature and is operator dependent. Digital Subtraction
Angiography (DSA) is considered the clinical gold stand-
ard for the diagnosis of PAD due to its high spatial and
temporal resolution [5]. In addition, treatment of signifi-
cant stenoses with balloon angioplasty and stenting can be
performed concurrently. However, DSA is utilized rela-
tively infrequently in practice as it is an invasive and ex-
pensive test and relies upon the use of ionizing radiation.
Computed tomography angiography (CTA) and magnetic
resonance angiography (MRA) are non-invasive alterna-
tives to DSA for the depiction of PAD [6, 7]. The diagnos-
tic performance of CTA and contrast-enhanced magnetic
resonance angiography (CE MRA) have been reported as
comparable to that of DSA in many studies [8, 9]. How-
ever, the high incidence of renal insufficiency in patients
with PAD raises the concern for nephrogenic systemic fi-
brosis (NSF) with respect to contrast enhanced MRA [10,
11]. The risk of NSF is eliminated with non-contrast en-
hanced magnetic resonance angiography (NCE-MRA)
techniques which have been developed as alternatives to
CE-MRA [12–14]. The Quiescent Interval Single-shot
(QISS) technique was developed as a safe and simple
“push-button” NCE MRA technique. It uses saturation
pulses to suppress background and venous signal, and is
ECG-gated to synchronize data acquisition with maximal
arterial inflow. The use of a single-shot 2D balanced
Steady State Free Precession (b-SSFP) sequence results in
clear depiction of arteries. The diagnostic performance of
QISS MRA has been reported to be comparable to that of
CE MRA [15]. To the best of our knowledge, there is no
study that has compared QISS at 3 T with CTA. Imaging
at 3 T is an attractive option due to the increased SNR
and the possibility to use higher parallel imaging acceler-
ation factors. The aim of the current study is to compare
non-contrast enhanced QISS MRA at 3 T with CTA for
the evaluation of lower extremity arterial disease.
Methods
Patients
This prospective study was approved by the local institu-
tional review board. Inclusion criteria were: (1) patients
with symptomatic lower extremity ischemia and (2)
patients who agreed to both CTA and non-contrast en-
hanced QISS MRA. Exclusion criteria were: (1) patients
with renal insufficiency (GFR < 30 ml/min/1.73 m2) in
whom CT contrast was contradicted and (2) patients
with contraindications to MR (i.e. A pacemaker or claus-
trophobia). From December 2014 to July 2015, 32 pa-
tients (23 men, 9 women, age range 40–81 years,
average age 61.97 years) met the inclusion criteria and
were enrolled in this study. Main symptoms of the pa-
tients were limb pain and claudication, with an average
duration of 11.5 months. Duration was less than
3 months for 5 patients, 3 ~ 12 months for 20 patients,
and more than 12 months for 7 patients. Creatinine level
was from 41 to 228 μmol/L, with an average of
76.3 μmol/L. Glomerular Filtration Rate (GFR) was from
34.5 to 149 ml/min/1.73 m2, with an average of
84.96 ml/min/1.73 m2. GFR was less than 60 ml/min/
1.73 m2 for 7 patients. Main pertinent medical history
was smoking (n = 14), diabetes (n = 19), hypertension (n
= 17) and coronary heart disease (n = 6). Written in-
formed consent was obtained from all patients before
the examinations. QISS MRA and CTA examinations
were performed on the same day. QISS MRA was per-
formed prior to CTA in 28 cases, and after CTA in 4
cases. 19 of the 32 patients underwent DSA for definitive
diagnosis or treatment within two days following CTA
and MRA.
MR angiography
All non-contrast enhanced QISS MRA examinations
were performed on a 3.0 T whole-body MR system
(MAGNETOM Skyra, Siemens Healthcare, Erlangen,
Germany). Patients were placed on the scanner in feet-
first supine position. A dedicated peripheral coil and two
eight-element body array coils were used to cover the
lower extremity and lower abdomen, and were combined
with the posterior integrated multi-channel spine coil.
Electrocardiographic triggering was used to ensure
proper synchronization between the arterial inflow
events and data sampling. Initially a scout image (Fas-
t_View_Scout) was performed of the whole lower ex-
tremity and abdomen for localization purposes using the
following parameters: TR/TE, 2.56/1.44 ms; FOV,
48 cm × 149 cm; slice thickness, 5 mm. QISS MRA was
performed in the transverse plane with the following pa-
rameters: TR = 1 heart beat; TE = 1.68 ms; flip angle, 90,
or reduced according to SAR limitation; bandwidth,
700Hz; FOV, 400 mm × 260 mm; matrix, 400 × 261;
number of slices, 40; slice thickness, 3 mm; GeneRalized
Autocalibrating Partially Parallel Acquisition (GRAPPA)
factor, 3 or 2. QISS was performed in 9 stations from
the distal calf to the lower abdomen in order to cover
the distal abdominal aorta. For the lower 7 stations, ac-
quisition time was equal to 40 heart beats at each station
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or approximately 0.5 min for a heart rate of 80/min. For
the upper two stations in the pelvis and lower abdomen,
only 10 slices were imaged during a breath hold,
followed by a rest interval of 8 s. The data acquisition
was performed in approximately 6.5 min, given an aver-
age heart rate of 80/min. The total study time was
lengthened by the shimming process, which was re-
peated at each station. Coronal Maximum Intensity Pro-
jection (MIP) images of each station were generated by
the scanner software, and all the MIP images were auto-
matically spliced into a composite image including the
entire region of interest.
CT angiography
All CTA examinations were performed at a 128-row CT
scanner (Discovery HD 750, GE medical, America), with
the following parameters: tube voltage, 100 Kv; tube
current, 150 mA; pitch, 0.984:1; table speed, 55 mm/s;
slice thickness, 0.625 mm; FOV, 50 cm. Iodinated con-
trast agent (Ultravist, Bayer, Germany, 1.2 ml/kg body
weight) was administered via an electronic power in-
jector (Stellant, MEDRAD, America) through an 18
gauge intravenous line placed in the right cubital vein, at
a rate of 3 ml/s. The bolus-tracking technique was used
whereby a region of interest (ROI) was positioned at the
aortic bifurcation. Image acquisition automatically
started 5.5 s after the attenuation in the ROI reached the
predefined threshold of 120 Hounsfield Units (HU).
Digital subtraction angiography
19 of 32 patients underwent DSA performed by an inter-
ventional radiologist with 15 years’ experience on a clin-
ical DSA unit (Allura Xper FD20, Philips Healthcare,
The Netherlands). 6 mL of iodinated contrast material
(Ultravist, Bayer, Germany) were administered intra-
arterially at a rate of 3 ml/s for each DSA run. 18 pa-
tients received balloon angioplasty duo to a severe sten-
osis or occlusion. Stents were placed in 5 cases. A
patient with thrombosis occluding the left femoral artery
received arterial embolectomy.
Data analysis
Post-processing procedures and measurement were per-
formed on a dedicated Siemens workstation (Syngo. Via,
Siemens Healthcare, Erlangen, Germany). CTA MIP im-
ages were reconstructed with a window setting of 600/
300 (window width/window level). Two readers with 10
and 8 years’ experience graded the image quality for
each segment using source images as well as recon-
structed images (MIP, and multi-planar reconstruction).
Image quality of the following 19 segments was evalu-
ated separately: 1, distal abdominal aorta; 2/3, common
iliac artery; 4/5, external iliac artery; 6/7, internal iliac ar-
tery; 8/9, femoral artery; 10/11, femoral profound artery;
12/13, popliteal artery; 14/15, anterior tibial artery; 16/
17, posterior tibial artery; 18/19, peroneal artery. The
readers blinded to clinical information evaluated seg-
ments in random order, using a 4-point scale: 1 = poor
or nondiagnostic arterial display; 2 = fair arterial display
and delineation of the arterial structures with detection
of lesions still possible; 3 = good arterial display without
impaired delineation of the vascular structures; 4 = ex-
cellent arterial display with sharp delineation of the ar-
teries throughout their length.
The arterial stenosis severity was rated by two readers
with 11 years’ and 9 years’ experience respectively.
Blinded readers were allowed to use both source images
and reconstructed images (including MIP, and multi-
planar reconstruction) for stenosis evaluation. A grading
system proposed by the American College of Radiology
in a multi-institutional trial of peripheral MRA was used
for arterial stenosis evaluation [16]: 0, normal; 1, min-
imal stenosis of less than 50 %; 2, one lesion with 50 %
or greater stenosis; 3, more than one lesion with 50 % or
greater stenosis; 4, occlusion. Each segment at QISS
MRA was assigned a score. Evaluation with CTA was
performed using the same criteria as with MRA. Inter-
modality agreement and interobserver agreement for
stenosis rating was determined on a per segment basis.
For the 19 patients with DSA examination, the seg-
ments at DSA and corresponding segments at MRA and
CTA were evaluated by two readers with 10 years’ and
11 years’ experience for the presence of significant sten-
osis (≥50 %). If multiple stenoses were found in a seg-
ment, the most severe stenosis was analyzed. One reader
evaluated QISS MRA segments first, then CTA. The
other reader evaluated CTA segments first, then QISS.
The interval between evaluations was 4 weeks to avoid
recall bias. Sensitivity, specificity, and accuracy of QISS
and CTA for detection of significant stenosis (≥50 %)
were calculated on a segment basis with DSA serving as
the reference standard.
Statistical analysis
All data analysis was performed using SPSS (version
21.0, IBM, America). Image quality was compared be-
tween CTA and QISS MRA using a Wilcoxon signed
rank test. The intermodality agreement between MRA
and CTA and interobserver agreement with each
method in assessment of arterial stenosis was deter-
mined with a Kappa test. Kappa > 0.8 was considered as
excellent agreement. 0.6–0.8 was considered good. 0.4–
0.59 was considered fair. Kappa < 0.4 was considered as
poor agreement. The sensitivity, specificity and accuracy
were calculated with DSA serving as the reference stand-
ard, and were compared between MRA and CTA using
a Spearman chi-square test. P-values less than 0.05 were
considered statistically significant.
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Results
All 32 patients completed the CTA and MRA examina-
tions successfully, without any adverse events. With 19
lower extremity arterial segments assessed per patient, a
total of 608 segments were evaluated. Segments with
nondiagnostic image quality (score 1) were not observed
with QISS MRA or CTA in the present study. 3.78 %
(23/608) MRA segments were rated as fair in quality
(score 2) by Reader1, and 3.62 % (22/608) by Reader 2.
77.96 % (474/608) MRA segments were rated as excel-
lent in quality (see Fig. 1) by Reader 1, and 78.29 %
(476/608) by Reader 2. 0.66 % (4/608) CTA segments
were rated as fair in quality (score 2) by Reader 1, and
0.33 % (2/608) by Reader 2. 92.27 % (561/608) CTA seg-
ments were rated as excellent in quality (score 4) by
Reader1, and 94.08 % (572/608) by Reader 2. Total
image quality of CTA was significantly higher than that
of QISS MRA (P < 0.001 for both readers, see Table 1).
Notably, the image quality of the two methods was not
statistically significantly different at some segments (P >
0.05 for both readers, see Table 1). Of the 608 segments
evaluated, 77 were heavily calcified segments. For these
segments, image quality of QISS were significantly
higher than that of CTA (P < 0.001 for both readers, see
Table 1).
15 of fair (score 2) segments at QISS were caused by
limb motion. In the pelvic region of 3 patients, vessel
blurring and misregistration due to respiratory artifacts
was observed. For one patient with orthopedic implant
at the right femur, image quality degradation of CTA
was not caused, while the QISS segment neighbor to
fixator (right femoral artery) was rated as fair (score 2).
Image degradation caused by the implant was not ob-
served at other segments of this patient. For 3 patients
with cardiac arrhythmia, QISS examination time was
lengthened, because data acquisition was not performed
every heart beat. Significant artifacts or image degrad-
ation was not observed.
Intermodality agreement in stenosis ratings was calcu-
lated on a per segment basis. Stenosis ratings were
equivalent with the two methods (Fig. 2) in 94.24 % seg-
ments (573/608) for Reader 1, and 94.74 % (576/608) for
Reader 2. Intermodality agreement was excellent for rat-
ing stenoses (kappa > 0.8, for both readers, see Table 2).
Interobserver agreement was excellent for both CTA
(0.936 ± 0.012) and MRA (0.935 ± 0.011).
In the present study DSA was performed on the seg-
ments where severe vascular disease was identified by
CTA/MRA. In total, 178 segments were evaluated with
DSA. Significant stenoses (≥50 %) were found in 85 seg-
ments (Fig. 3). Using DSA as the reference standard,
sensitivity of QISS MRA was 94.25 and 93.26 %, and
specificity was 96.70 and 97.75 %. Sensitivity, specificity
and accuracy of QISS MRA for the detection of signifi-
cant stenosis (≥50 %) were not statistically significantly
different from those of CTA (see Table 3). Of 178 seg-
ments evaluated with DSA, 41 segments were heavily
calcified. For these segments, sensitivity of QISS in de-
tecting significant stenoses (≥50 %) was significantly
higher than that of CTA (see Table 3).
Discussion
Given the high incidence of renal insufficiency in PAD
patients, the risk of contrast-induced nephropathy with
CTA and MRA are important concerns [17, 18]. In such
patients, non-contrast enhanced MRA is a promising al-
ternative. Various NCE MRA technologies have been
studied; however, none of them have been widely
adopted in clinical practice duo to various difficulties.
For example, 2D TOF has fallen into disuse because of
lengthy imaging time and poor image quality. Electrocar-
diographic gated 3D fast spin-echo sequences have been
shown to enable accurate imaging of the calf and pedal
arteries, but these techniques requires optimal selection
of systolic trigger delays [19, 20]. Flow-sensitive dephas-
ing (FSD) prepared balanced steady state free precession
sequence requires systolic and diastolic blood signal ac-
quisition, and permits visualization of arteries with sub-
traction [21]. However, the FSD technique is not user-
friendly as it requires the MR technologist to adjust mul-
tiple parameters from patient to patient [22]. QISS MRA
is a bright blood sequential 2D NCE MRA technique
originally developed for the evaluation of PAD [15].
Compared with other NCE MRA technologies, QISS has
an easy “push-button” workflow, eliminating the need
Fig. 1 a Segments including popliteal artery, anterior tibial artery,
posterior tibial artery and peroneal artery were rated as excellent in
quality with CTA. b These segments were rated as excellent in
quality with QISS MRA
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for extensive patient-to-patient parameter modification
[23]. QISS has been compared with ABI in screening
PAD [24], and has demonstrated a comparable diagnos-
tic performance to CE-MRA for PAD evaluation [15,
25]. QISS has also been compared favorably to other
NCE-MRA technique [26]. However, to the authors’
knowledge, QISS performance at 3 T has not been com-
pared with CTA, the predominant test for PAD in many
institutions because of its speed and accuracy. In the
current study, QISS at 3 T was compared to CTA
Table 1 Image quality was compared between CTA and MRA. 1 = poor or nondiagnostic arterial display; 2 = fair arterial display and
delineation of the arterial structures with detection of lesions still possible; 3 = good arterial display without impaired delineation of
the vessel structures; 4 = excellent arterial display with sharp delineation of the arteries throughout their length
Reader 1 Reader 2
CTA MRA P CTA MRA P
Distal abdominal aorta 3.91 ± 0.30 3.72 ± 0.46 0.034 3.94 ± 0.25 3.63 ± 0.49 0.002
Common iliac artery 3.86 ± 0.43 3.61 ± 0.55 0.003 3.88 ± 0.38 3.66 ± 0.48 0.002
External iliac artey 3.81 ± 0.50 3.55 ± 0.53 0.005 3.86 ± 0.39 3.64 ± 0.52 0.002
Internal iliac artery 3.63 ± 0.55 3.58 ± 0.56 0.554 3.64 ± 0.55 3.64 ± 0.48 0.981
Femoral artery 3.78 ± 0.49 3.67 ± 0.47 0.217 3.78 ± 0.55 3.61 ± 0.52 0.081
Femoral profound artery 3.97 ± 0.18 3.75 ± 0.44 <0.001 3.94 ± 0.24 3.77 ± 0.43 0.002
Popliteal artery 3.84 ± 0.41 3.75 ± 0.53 0.206 3.86 ± 0.39 3.78 ± 0.45 0.225
Anterior tibial artery 3.70 ± 0.46 3.78 ± 0.45 0.251 3.73 ± 0.45 3.80 ± 0.44 0.433
Posterior tibial artery 3.73 ± 0.45 3.80 ± 0.44 0.371 3.78 ± 0.42 3.80 ± 0.44 0.827
Peroneal artery 3.78 ± 0.42 3.81 ± 0.39 0.593 3.81 ± 0.43 3.84 ± 0.37 0.655
Total 3.80 ± 0.44 3.70 ± 0.49 <0.001 3.82 ± 0.42 3.72 ± 0.47 <0.001
Heavily calcified segment 3.13 ± 0.77 3.68 ± 0.59 <0.001 3.22 ± 0.68 3.65 ± 0.60 <0.001
CTA computed tomography angiography, MRA magnetic resonance angiography
Fig. 2 a Multiple stenoses at right femoral artery and occlusion (arrows) of right popliteal artery were shown with CTA image; however,
occlusions at bilateral lower leg were difficult to identify duo to multiple calcified plaques. b Occlusion of the right popliteal artery was also
shown with QISS (arrows). Calcified plaques were not problematic with QISS, with occlusions easily identified at calf. c Occlusion of the right
popliteal artery was proved by DSA (arrows). More collateral circulation vessels were shown with DSA
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finding excellent intermodality agreement in the assess-
ment of stenoses. For heavily calcified segments, the sen-
sitivity of QISS in detecting significant stenoses (≥50 %)
was significantly higher than that of CTA.
In the present study, the overall image quality of QISS
MRA was lower than that of CTA, the difference being
statistically significant. One possible explanation is that
the spatial resolution of CTA (1 mm × 1 mm×
0.625 mm) is greater than that of QISS MRA (1 mm ×
1 mm× 3 mm). Another possible explanation is that the
acquisition time of CTA is much shorter than MRA,
rendering it less prone to motion artifacts. However, it is
worth noting that the image quality of the two methods
was not significantly different at some segments.
Sufficiently suppressed background was observed in
the source images of QISS MRA, resulting from the in-
plane saturation pulse. The use of a gated acquisition
with a b-SSFP sequence ensured high blood signal and
adequate vessel-to-background contrast. Compared to
Table 2 Intermodality agreement between CTA and MRA in
rating stenosis. The arterial stenosis degree: 0, normal; 1,
minimal stenosis of less than 50 %; 2, one lesion with 50 % or
greater stenosis; 3, more than one lesion with 50 % or greater
stenosis; 4, occlusion
Reader 1 Reader 2
MRA MRA
0 1 2 3 4 0 1 2 3 4
CTA 0 217 11 0 0 0 0 216 11 0 0 0
1 4 150 3 1 0 1 3 152 2 1 0
2 0 5 43 2 0 2 0 5 45 2 0
3 0 2 4 74 1 3 0 1 5 74 0
4 0 0 0 2 89 4 0 0 0 2 89
kappa 0.923 ± 0.013 0.930 ± 0.012
CTA computed tomography angiography, MRA magnetic
resonance angiography
Fig. 3 Occlusion of right femoral artery was seen at CTA (a) and QISS MRA (b), and was proved by DSA (c). Stenosis degree is difficult to determine
duo to calcified plaques overlapping at CTA MIP image (arrows). Significant stenoses (arrows) were well seen at QISS MIP image (b) and DSA (c)
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other NCE-MRA techniques, QISS has superior flow
contrast, because the thin-slice 2D QISS acquisition
enables much greater replenishment of saturated arterial
spins compared to other thick-slab 3D acquisitions.
QISS is also relatively insensitive to patient motion due
to the 2D acquisition in the transverse plane. NCE QISS
MRA offers users the option of repeating acquisitions of
arterial segments in cases of poor image quality due to
motion or other technical limitations. For the current
study no acquisitions were repeated due to imaging time
considerations; however, this could be done in clinical
practice to potentially further improve image quality.
The intrinsically high blood signal intensity with the
b-SSFP sequence contributed to the image quality of
QISS [27]. QISS MRA was also performed at 3 T where
the intrinsic SNR is increased over lower field strengths
[28, 29]. The assessment of stenoses with MRA and
CTA was equivalent in most segments, and intermodal-
ity agreement was excellent. Thus, QISS MRA is a
promising alternative to CTA, in particular because
ionizing radiation and iodinated contrast are avoided.
2D QISS MRA with a slice thickness of 3 mm was
utilized in the present study. A thinner slice thickness
could be chosen; however, the number of slices required
to cover the field of view would be increased with an as-
sociated increase in scan acquisition time. For example,
the acquisition time doubles with slice thickness reduced
from 3 mm to 1.5 mm. A lengthy acquisition poses
difficulty for PAD patients with back or leg pain and the
inability to keep still in supine position for extended
periods. Fortunately, a 3 mm thickness was adequate for
assessment of PAD in the present study, and the
corresponding image acquisition time was acceptable
(6.5 min for heart rate of 80 per minute).
QISS was performed in the transverse plane, similar to
CTA. Because the scan direction was perpendicular to
the lower extremity artery, they were sensitive to sten-
oses in both anterior-posterior and left-right directions,
which may explain the excellent agreement in stenoses
rating. In the future clinical practice, through-plane
resolution could be further increased in a repeat-scan
for a more detailed analysis of suspected segments.
The reported sensitivity of CTA for the detection of
greater than 50 % stenosis is on the order of 89–100 %
[30]. Stenosis degree may be overestimated when severely
calcified antherosclerotic plaques were present [31].
Calcified plaque is not problematic with QISS MRA, likely
accounting for the higher sensitivity of the technique. The
diagnostic accuracy of QISS shown in the current study
indicates that it may be a promising alternative to DSA.
The present study has several limitations. First, the
sample size is small. More patients with lower extremity
PAD should be included in the future studies. Second,
DSA was available for only 19 patients. This reflects the
fact that CTA currently performs sufficiently well in
PAD patients to be considered the first-line examina-
tions for most patients. Due to its invasiveness and cost,
DSA was only performed on the patients with need of
definitive diagnosis or endovascular therapy. Third, DSA
was only performed on the diseased segments of the
lower extremity arteries. Ionizing radiation and contrast
administration would increase if all parts of lower ex-
tremity arterial vasculature were imaged. The number of
segments evaluated by DSA was thus relatively small,
weakening the statistical power. Fourth, the pedal arter-
ies were not evaluated in the present study. Arteries of
the foot are smaller in size and tortuous, thus making
the image quality provided by a 2D acquisition inad-
equate for evaluation. However, accurate diagnosis for
pedal PAD is as important as in the remainder of the
lower extremities, especially in patients with diabetes
[32]. Further advancement of NCE techniques will be re-
quired for sufficient evaluation of the pedal vasculature.
Finally, a head-to-head comparison was not performed
between QISS and other NCE MRA techniques as the
focus was on comparison with CTA.
Table 3 Sensitivity, specificity and accuracy of CTA and MRA in detecting significant stenoses (≥50 %) using DSA as the reference
standard
Reader 1 Reader 2
CTA MRA P CTA MRA P
All segments
Sensitivity 90.11 % (82/91) 94.25 % (82/87) 0.305 89.13 % (82/92) 93.26 % (83/89) 0.328
Specificity 96.55 % (84/87) 96.70 % (88/91) 0.955 96.51 % (83/86) 97.75 % (87/89) 0.622
Accuracy 93.26 % (166/178) 95.51 % (170/178) 0.357 92.70 % (165/178) 95.51 % (170/178) 0.261
Heavily calcified segments
Sensitivity 74.19 % (23/31) 95.83 % (23/24) 0.031 76.67 % (23/30) 95.83 % (23/24) 0.049
Specificity 90.00 % (9/10) 94.12 % (16/17) 0.693 90.91 % (10/11) 94.12 % (16/17) 0.747
Accuracy 78.05 % (32/41) 95.12 % (39/41) 0.023 80.49 % (33/41) 95.12 % (39/41) 0.043
CTA computed tomography angiography, MRA magnetic resonance angiography
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Conclusions
In conclusion, the extent and severity of lower extremity
PAD is accurately evaluated by NCE QISS MRA with a
typical acquisition time of 7–9 min. QISS is a reliable
alternative to CTA for this assessment, and may be
suitable as a first-line screening examination for lower
extremity PAD patients with contraindications to intra-
venous contrast administration.
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